Pictet Asset Management Holding SA »

Fate Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $39k 11k 3.50

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
BlackRock
Deep Track Capital
State Street Corporation
Boxer Capital
Bellevue Group
Citadel Advisors
Deerfield Management Company
Johnson & Johnson
D. E. Shaw & Co
Morgan Stanley
Woodline Partners
Baker Bros. Advisors

View all funds holding Fate Therapeutics